CGEM Stock Analysis: Buy, Sell, or Hold?
CGEM - Cullinan Therapeutics, Inc. Common Stock
$13.27
0.42 (3.27%)
▲
5d:
+3.35%
30d:
-14.39%
90d:
+27.97%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When CGEM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CGEM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CGEM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CGEM is currently trading at $13.27, which is considered fair relative to its 30-day fair value range of $13.10 to $15.35.
Technical Outlook: Technically, CGEM is in a strong uptrend. Immediate support is located at $12.40, while resistance sits at $14.74. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.35 (+144.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CGEM is in a strong uptrend. Immediate support is located at $12.40, while resistance sits at $14.74. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.35 (+144.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$13.10 -
$15.35
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 144.0% below Wall St target ($31.35)
Fair Price Analysis
30-Day Fair Range
$13.10 -
$15.35
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$12.40
Resistance Level
$14.74
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.40
Wall Street Target
$31.35
(+144.0%)
Share & Embed Analysis
Last updated: March 30, 2026 3:24 PM ET
Data refreshes hourly during market hours. Next update: 4:24 PM
Data refreshes hourly during market hours. Next update: 4:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jennifer Michaelson
SELL
8000 shares
2026-03-05
Jennifer Michaelson
SELL
1780 shares
2026-02-25
Jacquelyn L Sumer
SELL
3601 shares
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 61 BUY |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$134 | 59 HOLD |
